Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.

Pavón FJ, Araos P, Pastor A, Calado M, Pedraz M, Campos-Cloute R, Ruiz JJ, Serrano A, Blanco E, Rivera P, Suárez J, Romero-Cuevas M, Pujadas M, Vergara-Moragues E, Gornemann I, Torrens M, de la Torre R, Rodríguez de Fonseca F.

Addict Biol. 2013 Nov;18(6):955-69. doi: 10.1111/adb.12107. Epub 2013 Nov 14.

PMID:
24283982
2.

Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.

Pedraz M, Martín-Velasco AI, García-Marchena N, Araos P, Serrano A, Romero-Sanchiz P, Suárez J, Castilla-Ortega E, Barrios V, Campos-Cloute R, Ruiz JJ, Torrens M, Chowen JA, Argente J, de la Torre R, Santín LJ, Villanúa MÁ, Rodríguez de Fonseca F, Pavón FJ.

PLoS One. 2015 Mar 3;10(3):e0118610. doi: 10.1371/journal.pone.0118610. eCollection 2015.

3.

Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity.

Araos P, Pedraz M, Serrano A, Lucena M, Barrios V, García-Marchena N, Campos-Cloute R, Ruiz JJ, Romero P, Suárez J, Baixeras E, de la Torre R, Montesinos J, Guerri C, Rodríguez-Arias M, Miñarro J, Martínez-Riera R, Torrens M, Chowen JA, Argente J, Mason BJ, Pavón FJ, Rodríguez de Fonseca F.

Addict Biol. 2015 Jul;20(4):756-72. doi: 10.1111/adb.12156. Epub 2014 May 22.

PMID:
24854157
4.

[Psychopathological comorbidity in cocaine users in outpatient treatment].

Araos P, Vergara-Moragues E, Pedraz M, Pavón FJ, Campos Cloute R, Calado M, Ruiz JJ, García-Marchena N, Gornemann I, Torrens M, Rodríguez de Fonseca F.

Adicciones. 2014;26(1):15-26. Spanish.

5.

Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment.

Ziedonis DM, Rayford BS, Bryant KJ, Rounsaville BJ.

Hosp Community Psychiatry. 1994 Jan;45(1):43-9.

PMID:
8125458
6.
7.

Cocaine abuse or dependency and other pyschiatric disorders. Madrid study on dual pathology.

Arias F, Szerman N, Vega P, Mesias B, Basurte I, Morant C, Ochoa E, Poyo F, Babin F.

Rev Psiquiatr Salud Ment. 2013 Jul-Sep;6(3):121-8. doi: 10.1016/j.rpsm.2012.09.002. Epub 2012 Oct 31. English, Spanish.

8.

[Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].

Frei A, Rehm J; Arbeitsgruppe HeGeBe Doppeldiagnosen.

Psychiatr Prax. 2002 Jul;29(5):251-7. German.

PMID:
12101491
9.

Comorbidity and global functioning (DSM-III-R Axis V) in a Brazilian sample of cocaine users.

Razzouk D, Bordin IA, Jorge MR.

Subst Use Misuse. 2000 Aug;35(9):1307-15.

PMID:
11349687
10.

Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals.

Ford JD, Gelernter J, DeVoe JS, Zhang W, Weiss RD, Brady K, Farrer L, Kranzler HR.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):193-203. doi: 10.1016/j.drugalcdep.2008.07.004. Epub 2008 Sep 4.

11.

The relationship between child abuse and negative outcomes among substance users: psychopathology, health, and comorbidities.

Banducci AN, Hoffman E, Lejuez CW, Koenen KC.

Addict Behav. 2014 Oct;39(10):1522-7. doi: 10.1016/j.addbeh.2014.05.023. Epub 2014 Jun 2.

12.

Risperidone in cocaine-dependent patients with comorbid psychiatric disorders.

Albanese MJ, Suh JJ.

J Psychiatr Pract. 2006 Sep;12(5):306-11.

PMID:
16998418
13.

Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects.

Tang YL, Kranzler HR, Gelernter J, Farrer LA, Cubells JF.

Am J Addict. 2007 Sep-Oct;16(5):343-51.

PMID:
17882604
14.

Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.

Watkins KE, Hunter SB, Wenzel SL, Tu W, Paddock SM, Griffin A, Ebener P.

Am J Drug Alcohol Abuse. 2004 Nov;30(4):749-64.

PMID:
15624547
15.

Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS.

Fanelli F, Di Lallo VD, Belluomo I, De Iasio R, Baccini M, Casadio E, Gasparini DI, Colavita M, Gambineri A, Grossi G, Vicennati V, Pasquali R, Pagotto U.

J Lipid Res. 2012 Mar;53(3):481-93. doi: 10.1194/jlr.M021378. Epub 2011 Dec 14.

16.

Dysregulated responses to emotions among abstinent heroin users: correlation with childhood neglect and addiction severity.

Gerra G, Somaini L, Manfredini M, Raggi MA, Saracino MA, Amore M, Leonardi C, Cortese E, Donnini C.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:220-8. doi: 10.1016/j.pnpbp.2013.10.011. Epub 2013 Oct 23.

PMID:
24161666
17.

DHEAS and POMS measures identify cocaine dependence treatment outcome.

Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D, Setoda D.

Psychoneuroendocrinology. 2005 Jan;30(1):18-28.

PMID:
15358439
18.

Liquid chromatography-tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cells.

Balvers MG, Wortelboer HM, Witkamp RF, Verhoeckx KC.

Anal Biochem. 2013 Mar 15;434(2):275-83. doi: 10.1016/j.ab.2012.11.008. Epub 2012 Nov 29.

PMID:
23201387
19.

Gender differences in psychiatric comorbidity among cocaine-using opiate addicts.

Magura S, Kang SY, Rosenblum A, Handelsman L, Foote J.

J Addict Dis. 1998;17(3):49-61.

PMID:
9789159
20.

[Substance use, affective problems and personality traits: test of two association models].

Chakroun N, Doron J, Swendsen J.

Encephale. 2004 Nov-Dec;30(6):564-9. French.

PMID:
15738859
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk